C25H29BrN8O2
Neat
553.47
1446263-39-3; (R, E)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2, 6(3H, 7H)-dione; 1H-Purine-2, 6-dione, 8-[(3R)-3-amino-1-piperidinyl]-7-[(2E)-3-bromo-2-buten-1-yl]-3, 7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-; N-Des-(2-butyn-1-yl)-N-(3-bromo-2-buten-1-yl) Linagliptin (E/Z Mixture); SCHEMBL15083817; 8-[(3R)-3-Amino-1-piperidinyl]-7-[(2Z)-3-bromo-2-buten-1-yl]-3, 7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2, 6-dione; CS-M2711; D77481; F789857; (R, E)-8-(3-aminopiperidin-1-yl)-7-(3-bromobut-2-en-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-3, 7-dihydro-1H-purine-2, 6-dione; 8-[(3R)-3-Amino-1-piperidinyl]-7-[(2E/Z)-3-bromo-2-buten-1-yl]-3, 7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2, 6-dione; Linagliptin Impurity S; 8-[(3R)-3-aminopiperidin-1-yl]-7-[(E)-3-bromobut-2-enyl]-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2 and 6-dione
8-[(3R)-3-aminopiperidin-1-yl]-7-[(E)-3-bromobut-2-enyl]-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2 and 6-dione
InChI=1S/C25H29BrN8O2/c1-15(26)10-12-33-21-22(30-24(33)32-11-6-7-17(27)13-32)31(3)25(36)34(23(21)35)14-20-28-16(2)18-8-4-5-9-19(18)29-20/h4-5,8-10,17H,6-7,11-14,27H2,1-3H3/b15-10+/t17-/m1/s1